New Peer-Reviewed Publication Shows Multi-Omic Blood Test Achieves High Sensitivity For Early-Stage Ovarian Cancer Detection
AOA Dx (AOA), a leader in blood-based diagnostics for early cancer detection, has published peer-reviewed clinical evidence showing high accuracy in detecting ovarian cancer in symptomatic women—a group where early diagnosis is essential yet often missed. This breakthrough highlights the potential to transform outcomes for women at risk.